UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
Commission File Number: 333-145620
 
China BCT Pharmacy Group, Inc.
(Exact name of registrant as specified in its charter)
 
No. 102, Chengzhan Road
Liuzhou City, Guangxi Province, P.R.C. 545007
(86) 772-363-8318  
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Common Stock, par value $0.001 per share  
(Title of each class of securities covered by this Form)
 
None.  
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
Rule 12g-4(a)(1)
x
Rule 12g-4(a)(2)
¨
Rule 12h-3(b)(1)(i)
x
Rule 12h-3(b)(1)(ii)
¨
Rule 15d-6
¨
 
Approximate number of holders of record as of the certification or notice date:   141
 
Pursuant to the requirements of the Securities Exchange Act of 1934, China BCT Pharmacy Group, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 
 
Date: May 28, 2013
By:
/s/   Huitian Tang  
    Name: Huitian Tang  
    Title: Chief Executive Officer  
       

China BCT Pharmacy (CE) (USOTC:CNBI)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more China BCT Pharmacy (CE) Charts.
China BCT Pharmacy (CE) (USOTC:CNBI)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more China BCT Pharmacy (CE) Charts.